𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix

✍ Scribed by Ron C. Rietbroek; Marten S. Schilthuis; Piet J. M. Bakker; Jan D. P. van Dijk; Arjan J. Postma; Dionisio González González; Ad J. Bakker; Jacobus van der Velden; Theo J. M. Helmerhorst; Cees H. N. Veenhof

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
110 KB
Volume
79
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Phase II Trial of Weekly Locoregional Hyperthermia and Cisplatin in Patients with a Previously Irradiated Recurrent Carcinoma of the Uterine Cervix

BACKGROUND. The biologic rationale for combining cisplatin with locoregional Ron C

📜 SIMILAR VOLUMES

A Phase II trial of methotrexate, vinbla
A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix
✍ Christos A. Papadimitriou; Meletios A. Dimopoulos; Nikolaos Giannakoulis; Kyrill 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## Background: Patients with metastatic carcinoma of the uterine cervix have limited survival. thus, new chemotherapeutic agents and combinations are needed to improve patient outcome. ## Methods: Twenty-seven patients with stage iv primary or recurrent carcinoma of the uterine cervix were assign

A multicenter, Phase II trial of weekly
A multicenter, Phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
✍ Mace L. Rothenberg; John V. Cox; Russell F. DeVore; John D. Hainsworth; Richard 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views

## Background: This multicenter, phase ii trial was performed to evaluate the antitumor activity and toxicity of irinotecan (cpt-11) in patients with metastatic colorectal carcinoma that had recurred or progressed after 5-fluorouracil (5-fu)-based chemotherapy. ## Methods: Cpt-11 was given as a 9

Phase II study of carboplatin and liposo
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix
✍ Claire F. Verschraegen; John J. Kavanagh; Evelyne Loyer; Diane Bodurka-Bevers; A 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## BACKGROUND. The activity of the combination of carboplatin and liposomal doxorubicin was tested in a Phase II study of patients with recurrent cervical carcinoma. ## METHODS. The combination of carboplatin (area under the concentration curve [AUC], 5) and liposomal doxorubicin (Doxil; starti

A phase II trial of neoadjuvant methotre
A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma
✍ Louise E. Morrell; Young J. Lee; Judith Hurley; Mayda Arias; Carolyn Mies; Steph 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: Traditionally, primary surgical therapy is considered unsuitable for the treatment of patients with locally advanced breast carcinoma (labc). multiple reports have documented the efficacy of primary chemotherapy in this group of patients. the purpose of this study was to investigate

A phase I/II trial of neoadjuvant chemot
A phase I/II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma
✍ Jean Viallet; Marc-André Brassard; Luis Souhami; Joseph Ayoub; Pierre Del Vecchi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

## BACKGROUND. Both locoregional and distant disease control remains poor in the treatment of Stage III nonsmall cell lung carcinoma (NSCLC). This trial was conducted to evaluate the tolerance and responses of patients with NSCLC given a neoadjuvant regimen of cisplatin and vinorelbine chemotherapy

Phase II trial of chemotherapy with 5-fl
Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type
✍ Abdelkrim Taamma; Abdelrahim Fandi; Nacer Azli; Pierre Wibault; Nadia Chouaki; A 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## BACKGROUND. The aim of this study was to evaluate the toxicity and efficacy of the combination of 5-fluorouracil, bleomycin, epirubicin, and cisplatin (FBEC) in the treatment of patients with undifferentiated carcinoma of nasopharyngeal type (UCNT). The study included patients with metastatic or